Ukraine’s World-Class Drug-Molecule Industry Imperiled by Russia Invasion – The Wall Street Journal

Russian attacks are endangering Ukraine’s world-leading medicinal chemistry industry, which supplies scientists across the globe with molecular building blocks needed for early drug development.
Ukraine’s dominance in medicinal chemistry is little known beyond drug developers, who fine-tune a drug’s molecular design to give it the best chance of hitting the desired biological target in the body. Kyiv-based Enamine Ltd. has become a go-to supplier for drug-discovery scientists at academic laboratories and the largest pharmaceutical companies.
To Read the Full Story
Continue reading your article with
a WSJ membership
WSJ Membership
Customer Service
Tools & Features
Ads
More
Dow Jones Products
WSJ Membership
Customer Service
Tools & Features
Ads
More

source